FOUND: 11 - You Need To See This

New rice strain able to tolerate flooding

A research team from the National Centre for Genetic Engineering and Biotechnology (Biotec) has succeeded in developing a new rice strain called Hom Le Noi that can reportedly withstand the effects of flooding.

Bangkok Post · Sep 29, 2022

3 Biotech Stocks That'll Make You Richer and 1 That Won't

The biotech industry continues to stay resilient to broader economic challenges. Moreover, the planned multi-million-dollar government investments should bode well for the industry. Hence, quality biotech stocks Amgen (AMGN), Gilead Sciences (GILD), and Biogen (BIIB) could be ideal buys to cash in on the industry’s prospects. However, fundamentally weak stock…

StockNews.com · Sep 29, 2022

New method of preserving donated kidneys ‘could mean fewer organs wasted’

The technique could keep kidneys viable for longer and increase the number available for transplant.

The Independent UK · Sep 25, 2022

Riyadh, Tashkent to Expand Cooperation in Tech, Petrochemical Industries

Ahead of the visit of Uzbek President Shavkat Mirziyoyev to Saudi Arabia, the embassy of Uzbekistan in Riyadh expected a rapid and dynamic development of bilateral cooperation between the two countries. Cooperation is expected in the fields of energy, information technology, telecommunications, health, biotechnology and agriculture, in addition to forestry,…

Asharq Al-Awsat · Aug 17, 2022

5 Biotech Stocks in the Buy Zone This Week

The biotech industry is expected to see solid growth in the long term due to rising healthcare spending, breakthrough developments, and an aging population. Given the industry’s solid growth prospects and non-cyclical nature, it could be wise to invest in fundamentally strong biotech stocks Gilead Sciences (GILD), Biogen (BIIB), Jazz…

StockNews.com · Aug 16, 2022

Recap Of Friday's Biotech Catalysts - End Of the Day Summary

Pfizer (NYSE:PFE) announced positive top-line results from its pivotal U.S. Phase 3 study in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive pneumococcal disease (IPD). The study met two co-primary objectives, associated with immunogenicity responses. Pfizer shares traded in a range of $48.55 to…

Benzinga · Aug 12, 2022

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Aug 4, 2022

Don't Rule out a Summer Rally for This 1 Biotech Stock

Leading biotechnology company Vertex Pharmaceuticals (VRTX) has achieved strong top and bottom-line growth in its last quarter. Furthermore, the company is well-positioned to benefit from its diversified pipeline of transformative small-molecule, cell, and genetic therapies. Thus, even after gaining 27.5% year-to-date, we think VRTX still has decent upside potential. Read…

StockNews.com · Jul 26, 2022

5 Biotech Stocks to Buy and Hold for the Next Decade

The biotech industry seems poised to witness solid growth over the next decade with intensive innovation, breakthrough developments, and growing investments in the sector. So, given analysts’ promising growth outlook for the industry, it could be wise for investors to buy and hold fundamentally solid biotech stocks Vertex Pharmaceuticals (VRTX),…

StockNews.com · Jul 26, 2022

4 Downgraded Stocks You'll Want to Sell or Avoid Right Now

With the growing odds of the economy tipping into a recession due to an aggressive monetary policy tightening to tame the sky-high inflation, it could be difficult for fundamentally weak stocks to stay afloat. Invesco (IVZ), Kymera (KYMR), Mogo (MOGO), and Sana Biotechnology (SANA) have been recently downgraded by our…

StockNews.com · Jul 25, 2022